Learn More
Selleck Chemical LLC LY2109761 5mg 700874-71-1

Supplier: Selleck Chemical LLC S27045MG
LY2109761 is a novel selective TGF-? receptor type I/II (T?RI/II) dual inhibitor with Ki of 38 nM and 300 nM in a cell-free assay, respectively; shown to negatively affect the phosphorylation of Smad2. LY2109761 blocks autophagy and induces apoptosis. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.